Jun 4, 2026 08:00AM
May 15, 2026 06:00AM
Apr 15, 2026 06:06AM
Apr 15, 2026 06:05AM
Mar 27, 2026 09:49AM
Mar 27, 2026 08:00AM
Mar 27, 2026 08:00AM ARS Pharmaceuticals Receives FDA Approval to Remove Age Requirement From neffy® 1 mg (epinephrine nasal spray) Label
Mar 9, 2026 06:00AM
Mar 2, 2026 06:37AM
Feb 10, 2026 08:00AM
Feb 2, 2026 08:00AM
Feb 2, 2026 08:00AM
Jan 21, 2026 08:00AM
Dec 29, 2025 08:00AM neffy epinephrine nasal spray wins approval in China
Dec 29, 2025 08:00AM
Nov 10, 2025 06:00AM
Nov 4, 2025 08:00AM
Nov 3, 2025 02:23PM
Nov 3, 2025 02:23PM
Nov 3, 2025 07:45AM
Nov 3, 2025 07:45AM ARS Pharma to Present Real-World Data on Intranasal Epinephrine at 2025 American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting
Oct 8, 2025 08:00AM
Oct 8, 2025 08:00AM
Sep 29, 2025 04:06PM
Sep 29, 2025 04:05PM
Sep 19, 2025 08:01AM
Sep 19, 2025 08:00AM
Sep 8, 2025 08:00AM Real-World Evidence Supports Clinical Effectiveness of neffy® (epinephrine nasal spray) in Patients Experiencing Anaphylaxis
Aug 13, 2025 07:00AM
Jul 18, 2025 09:26AM
Jul 18, 2025 09:25AM
May 14, 2025 07:00AM
May 7, 2025 08:00AM
May 7, 2025 08:00AM
May 2, 2025 08:00AM ARS Pharmaceuticals Announces Co-Promotion Agreement with Partner and Global Allergy Leader ALK-Abelló A/S to Expand Reach of neffy® (epinephrine nasal spray) to Additional U.S. Pediatricians
Mar 20, 2025 07:00AM
Mar 5, 2025 04:11PM
Mar 5, 2025 04:10PM
Mar 5, 2025 04:10PM
Feb 20, 2025 07:02PM
Feb 18, 2025 08:00AM
Jan 21, 2025 08:00AM ARS Pharmaceuticals Launches neffyinSchools Program Providing Free Life-Saving Needle-Free Epinephrine For Emergency Use to Eligible K-12 Schools
Jan 13, 2025 08:00AM
Jan 6, 2025 08:10AM
Jan 6, 2025 08:00AM
Dec 19, 2024 05:25PM
Dec 12, 2024 02:33PM
Dec 12, 2024 02:32PM
Dec 4, 2024 08:00AM ARS Pharmaceuticals Announces Planned Launch of neffyinSchools Program to Provide Life-Saving Needle Free Epinephrine to Eligible K-12 Schools at No Cost
Nov 13, 2024 06:30AM

322,243 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All